Literature DB >> 30001463

Impact of Software Selection and ImageJ Tutorial Corrigendum on Skeletal Muscle Measures at the Third Lumbar Vertebra on Computed Tomography Scans in Clinical Populations.

Levi M Teigen1, Adam J Kuchnia1, Emily Nagel1, Christopher Deuth1, David M Vock2, Urvashi Mulasi3, Carrie P Earthman1.   

Abstract

BACKGROUND: There is growing interest in computed tomography (CT) measures of skeletal muscle cross-sectional area (CSA) for nutrition assessment. Multiple software programs are available, but little work has been done comparing programs. We aimed to determine if CT-derived measures of skeletal muscle CSA at the level of the L3 are influenced by the software program used. We also demonstrate the importance of the ImageJ corrigendum published in this journal.
METHODS: Two software programs, National Institutes of Health ImageJ and Tomovision sliceOmatic, were compared. ImageJ measures were obtained using both the original tutorial and corrigendum instructions. Skeletal muscle CSA at the level of the L3 was measured in advanced heart failure and head and neck cancer populations by 3 different investigators. Intraclass correlation coefficients were used to calculate intrarater and interrater reliability. Bland-Altman analysis was used to assess agreement.
RESULTS: Both software programs yielded excellent intrarater and interrater reliability scores (intraclass correlation coefficients, 0.985-1.000). The overall mean difference (ImageJ tutorial with corrigendum - sliceOmatic) for the entire sample (N = 51) was found to be 1.53 cm2 (95% CI, 0.59-2.47 cm2 ). The overall mean difference (ImageJ corrected - original) for the entire sample (N = 51) was found to be -11.35 cm2 (95% CI, -12.75 to -9.95 cm2 ).
CONCLUSION: Measures of skeletal muscle CSA at the L3 were found to be ∼1.53 cm2 higher with ImageJ than sliceOmatic. This difference was not found to affect interpretation against a published cut point. The importance of accounting for the ImageJ tutorial corrigendum was shown to be clinically significant when applied to published cut points.
© 2017 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  body composition; computed tomography; malnutrition; skeletal muscle; software

Mesh:

Year:  2017        PMID: 30001463     DOI: 10.1002/jpen.1036

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

1.  The ImageJ ecosystem: Open-source software for image visualization, processing, and analysis.

Authors:  Alexandra B Schroeder; Ellen T A Dobson; Curtis T Rueden; Pavel Tomancak; Florian Jug; Kevin W Eliceiri
Journal:  Protein Sci       Date:  2020-11-20       Impact factor: 6.725

Review 2.  The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review.

Authors:  Tanvir Abbass; Ross D Dolan; Barry J Laird; Donald C McMillan
Journal:  Cancers (Basel)       Date:  2019-09-04       Impact factor: 6.639

3.  Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer.

Authors:  Chao Zheng; Ellen Wang; Jiang-Shan Li; Kai Xie; Chao Luo; Qi-Yue Ge; Li-Wen Hu; Yi Shen
Journal:  BMC Geriatr       Date:  2022-03-15       Impact factor: 3.921

4.  Prevention of muscle atrophy in ICU patients without nerve injury by neuromuscular electrical stimulation: a randomized controlled study.

Authors:  Weiwei Bao; Jiajia Yang; Mingna Li; Kang Chen; Zheng Ma; Yuehong Bai; Yiming Xu
Journal:  BMC Musculoskelet Disord       Date:  2022-08-16       Impact factor: 2.562

5.  Computed tomography-based psoas skeletal muscle area and radiodensity are poor sentinels for whole L3 skeletal muscle values.

Authors:  Katie E Rollins; Aravin Gopinath; Amir Awwad; Ian A Macdonald; Dileep N Lobo
Journal:  Clin Nutr       Date:  2019-10-14       Impact factor: 7.324

6.  Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.

Authors:  Carole Bouleuc; Amélie Anota; Cécile Cornet; Ghislain Grodard; Antoine Thiery-Vuillemin; Olivier Dubroeucq; Nathalie Crétineau; Véronique Frasie; Vincent Gamblin; Gisèle Chvetzoff; Laure Favier; Christophe Tournigand; Marie-Christine Grach; Bruno Raynard; Sébastien Salas; Géraldine Capodano; Lionel Pazart; Régis Aubry
Journal:  Oncologist       Date:  2020-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.